| mupirocin / Generic mfg. |
SJMRSA, NCT00713674: Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx |
|
|
| Withdrawn | N/A | 0 | NA | Theraworx, mupirocin antibiotic ointment | Mercy Research | Methicillin-Resistant Staphylococcus Aureus | 02/09 | 02/09 | | |
StLStaRS, NCT00513799: The Natural History of Community-Associated MRSA Infections and Decolonization Strategies |
|
|
| Completed | N/A | 300 | US | Mupirocin ointment, Bactroban, Chlorhexidine showers, Hibiclens, Bleach baths (dilute), Clorox, Intensive education on personal hygiene | Washington University School of Medicine | Abscesses, Furunculosis, Staphylococcus Aureus, Staphylococcal Skin Infections | 06/09 | 12/10 | | |
NCT01049438: A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections |
|
|
| Completed | N/A | 31 | US | nasal mupirocin, Bactrban Nasal, topical 3% hexachlorophene body wash, Phisohex, oral anti-MRSA antibiotic, trimethoprim-sulfamethoxazole, doxycycline, minocycline | Natividad Medical Center | Methicillin Resistant Staphylococcus Aureus Skin Infections | 09/09 | 09/09 | | |
| Completed | N/A | 183 | US | 2% Mupirocin Ointment, Bactroban, 4% Chlorhexidine liquid soap, Hibiclens, Hygiene protocol | Washington University School of Medicine | Staphylococcal Skin Infections, Abscesses, Furunculosis, Staphylococcus Aureus, MRSA Infection | 01/10 | 12/10 | | |
NCT00980980: Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs) |
|
|
| Completed | N/A | 74256 | US | Chlorhexidine bath and nasal mupirocin | Harvard Pilgrim Health Care, Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention, Hospital Corporation of America, University of California, Irvine, Department of Population Medicine, Harvard Medical School / Harvard Pilgrim Healthcare Institute | Methicillin-resistant Staphylococcus Aureus | 09/11 | 09/11 | | |
NCT01232231: Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting |
|
|
| Completed | N/A | 15 | Canada | pharmacological decolonization treatment, Education | Joseph Kim, Alberta Health services | Methicillin-resistant Staphylococcus Aureus | 04/12 | 11/12 | | |
| Completed | N/A | 1 | US | Retapamulin, Co-prescription of retapamulin and topical mupirocin, Co-prescription of retapamulin and topical fusidic acid | GlaxoSmithKline | Impetigo | 08/12 | 08/12 | | |
NCT01153880: United States Pharmacovigilence Retapamulin-Prescribing |
|
|
| Completed | N/A | 1 | US | Retapamulin, Co-prescription of retapamulin and topical mupirocin | GlaxoSmithKline | Skin Infections, Bacterial | 08/12 | 08/12 | | |
| Completed | N/A | 474 | US | 2% mupirocin ointment, Bactroban, Bleach Bath (dilute), Clorox, Hygiene Protocol | Washington University School of Medicine | Staphylococcal Skin Infection, Abscess, Furunculosis, Staphylococcus Aureus, MRSA Infection | 02/17 | 11/17 | | |
MRSA, NCT00631566: Prospective Study of Methicillin-Resistant Staphylococcus Aureus () Among HIV-Infected Persons |
|
|
| Completed | N/A | 550 | US | Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%, Placebo | Henry M. Jackson Foundation for the Advancement of Military Medicine, Infectious Diseases Clinical Research Program, National Institute of Allergy and Infectious Diseases (NIAID), US Military HIV Research Program | HIV Infections, Staphylococcal Infections | 05/17 | 10/17 | | |
